Supplementary Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

Abstract

Table S1. Combined positivity score (CPS) in responders and non-responders at baseline. Table S2. Immunohistochemistry markers evaluated at baseline and on-treatment.